Immunotherapy can be powerful—especially when biomarkers and tumor characteristics support it. The goal is to make immunotherapy decisions with stronger evidence and better readiness
Immunotherapy is a category of treatments that helps the immune system recognize and fight cancer.
Many immunotherapy decisions involve evaluating tumor and immune markers. The quality and availability of tissue can influence how confidently your team can assess those markers—and whether you can pursue additional testing later if needed.
Only your care team can determine fit. The purpose of better testing and preservation is to support clearer decision-making—not promises.
It depends on your clinical goals and what your doctor wants to evaluate.
Immunotherapy can be powerful—especially when biomarkers and tumor characteristics support it. The goal is to make immunotherapy decisions with stronger evidence and better readiness
Immunotherapy is a category of treatments that helps the immune system recognize and fight cancer.
Many immunotherapy decisions involve evaluating tumor and immune markers. The quality and availability of tissue can influence how confidently your team can assess those markers—and whether you can pursue additional testing later if needed.
Only your care team can determine fit. The purpose of better testing and preservation is to support clearer decision-making—not promises.
It depends on your clinical goals and what your doctor wants to evaluate.
